tirzepatide and metformin Together: Combination Therapy Guide Can you take metformin and

Currently, 70% of the GLP-1 market is in the US and partially the EU, with a staggering 300% growth from 2020 to 2023 in prescriptions within the US alone

Cagrilintide is not approved for any indication anywhere

Bone health is also a concern with GLP-1 medications, especially for women in menopause who are already at risk for bone loss

The argument is that these compounded versions are often cheaper alternatives, especially for weight loss, where insurance coverage is limited

Studies of weight loss interventions consistently show that insufficient protein during caloric restriction accelerates muscle loss, reduces resting metabolic rate, and may contribute to weight regain after treatment cessation